Back

Intra-Cellular Therapies Stock Predictions

Wall Street's Worst Nightmare: Small Town Trader's AI Edge

See the AI advantage for everyday Americans.

Sell

ITCI
Intra-Cellular Therapies

Last Price:

80.46

Seasonality Move:

-0.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Free presentation on how to trade options for overnight gains

Get the free overnight options training here.

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 40.8% based on the past 10 years of stock performance.
Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $80.85. The Score for ITCI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 40.8% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell

Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

84.89

52-Week Low:

45.50

Prediction Charts

Market Cap:

8.54B

Price in USD:

80.85

Volume:

1.45M

Beta:

1.07

Technical Analysis

SMA50:

71.00

SMA100:

69.88

SMA200:

66.40

52-Wk Change:

33.13%

Stock Predictions

Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 80.85 USD today.
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jul-8	69.53	71.56	71.72	68.98
Jul-9	71.68	74.07	74.36	71.25
Jul-10	75.14	77.29	77.56	74.54
Jul-11	77.40	78.36	79.71	77.21
Jul-12	78.31	78.12	79.03	77.48
Jul-15	78.10	78.72	79.03	77.57
Jul-16	79.26	78.57	79.88	78.46
Jul-17	77.90	76.58	78.62	75.94
Jul-18	76.53	74.94	76.83	74.45
Jul-19	75.24	74.86	76.10	74.48
Jul-22	75.75	76.48	76.55	74.62
Jul-23	76.48	78.20	79.38	75.59
Jul-24	77.88	77.27	78.29	77.05
Jul-25	77.11	80.85	81.82	77.11

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.09 per share, an increase this year of $1.09 per share, and an increase next year of $1.57 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.